ValiRx plc (AIM:VAL)

ValiRx Income Statement

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	0.05	0.01	-	-	-
Revenue Growth (YoY)	418.49%	-	-	-	-
Cost of Revenue	-	0	-	-	-
Gross Profit	0.05	0.01	-	-	-
Selling, General & Admin	1.98	1.89	1.5	1.22	1.43
Research & Development	0.25	0.38	0.55	0.3	0.23
Other Operating Expenses	-0.03	-	-	-0.03	-0.01
Operating Expenses	2.19	2.31	2.59	1.68	1.65
Operating Income	-2.14	-2.3	-2.59	-1.68	-1.65
Interest Expense	-0	-0	-0.01	-0	-0.01
Other Non Operating Income (Expenses)	0.01	-	-	-	-0.01
EBT Excluding Unusual Items	-2.13	-2.3	-2.6	-1.68	-1.67
Other Unusual Items	-	-	-	-	0.12
Pretax Income	-2.13	-2.3	-2.6	-1.68	-1.54
Income Tax Expense	-0.13	-0.18	-0.19	-0.13	-0.08
Earnings From Continuing Operations	-2	-2.13	-2.41	-1.55	-1.47
Net Income to Company	-2	-2.13	-2.41	-1.55	-1.47
Minority Interest in Earnings	0.09	0.09	0.04	0.03	0.03
Net Income	-1.92	-2.04	-2.37	-1.52	-1.44
Net Income to Common	-1.92	-2.04	-2.37	-1.52	-1.44
Shares Outstanding (Basic)	132	102	77	65	38
Shares Outstanding (Diluted)	132	102	77	65	38
Shares Change (YoY)	30.08%	31.39%	18.92%	71.53%	424.82%
EPS (Basic)	-0.01	-0.02	-0.03	-0.02	-0.04
EPS (Diluted)	-0.01	-0.02	-0.03	-0.02	-0.04
Free Cash Flow	-1.62	-2.06	-1.71	-1.26	-1.91
Free Cash Flow Per Share	-0.01	-0.02	-0.02	-0.02	-0.05
Gross Margin	100.00%	85.00%	-	-	-
Operating Margin	-4302.70%	-23943.12%	-	-	-
Profit Margin	-3848.71%	-21226.05%	-	-	-
Free Cash Flow Margin	-3260.70%	-21495.13%	-	-	-
EBITDA	-1.87	-2.05	-2.39	-1.46	-1.42
D&A For EBITDA	0.27	0.25	0.2	0.22	0.23
EBIT	-2.14	-2.3	-2.59	-1.68	-1.65

Updated Sep 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.